プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Mohammad M.に依頼

Japan

PhD Neuroscientist | Scientific Writer | ALS/FTLD Research Specialist

プロフィール概要

I am a PhD-trained neuroscientist with extensive experience in molecular neuroscience, specializing in ALS/FTLD and RNA-binding protein biology. My research focuses on oligonucleotide-based modulation of FUS phase separation, with demonstrated success across in vitro systems, iPSC-derived motor neurons, and in vivo models. I am the inventor of a patented oligonucleotide therapeutic approach targeting protein phase behavior in neurodegeneration, and I have hands-on expertise in experimental design, data interpretation, and translational research. I provide: • Scientific manuscript writing and editing (publication-ready) • Grant writing (fellowships, academic funding, early-stage proposals) • Literature reviews and research synthesis • Experimental design and research consulting (AD, ALS, iPSC, LLPS) I have contributed to peer-reviewed publications and international conferences, and I understand what reviewers and funding bodies expect. If you are looking for precise, high-quality scientific support grounded in real research experience, I would be glad to collaborate.

専門分野

• ★ Neurobiology
• ★ Medical Writing
• ★ Science Communication
• ☆ Molecular Biology
• ☆ Cell Biology
• ☆ Stem Cell Research
• ☆ Biotechnology & Bioengineering
• ☆ Science Outreach
• ☆ Drug Discovery
• ☆ Scientific Proofreading & Editing
• ☆ Proofreading & Editing
• ☆ Grant Writing

サービス

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Clinical Trial Documentation, Medical Writing, Non-Medical Regulatory Writing, Technical Writing

Research Technology Scouting, Fact Checking, Gap Analysis, Gray Literature Search, Scientific and Technical Research, Systematic Literature Review

Consulting Healthcare Consulting, Scientific and Technical Consulting

Data & AI Statistical Analysis, Image Processing, Image Analysis, Data Visualization

Product Development Concept Development

職務経験

Specially Appointed Assistant Professor

Shiga University of Medical Science

5月 2022 - 現在

Specially Appointed Assistant Professor

Shiga University of Medical Science

5月 2022 - 現在

Researcher

Nagoya University

4月 2021 - 3月 2022

Postdoctroral Researcher

Doshisha University

4月 2019 - 3月 2021

学歴

Molecular Neuropathology

Doshisha University - Japan

9月 2015 - 9月 2018

Medical Life Systems

Doshisha University - Japan

9月 2013 - 9月 2015

Biotechnology and Genetic Engineering

Islamic University, Bangladesh

1月 2006 - 12月 2010

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Moniruzzaman Mohammad, Kuniyuki Iwata-Endo, Kentaro Sahashi, Kaori Kawai, Yusuke Fujioka, Yohei Okada, Eri Watanabe, Nobuyuki Iwade, Minaka Ishibashi, Asraa Faris Aldoghachi, et al. (2025). Correcting tau isoform ratios with a long-acting antisense oligonucleotide alleviates 4R-tauopathy phenotypes . Molecular Therapy Nucleic Acids.

Moniruzzaman Mohammad, Yoshiyuki Soeda, Emi Hayashi, Naoko Nakatani, Shinsuke Ishigaki, Yuta Takaichi, Taro Tachibana, Yuichi Riku, James K. Chambers, Riki Koike, et al. (2024). A novel monoclonal antibody generated by immunization with granular tau oligomers binds to tau aggregates at 423-430 amino acid sequence . Scientific Reports.

Mohammad Moniruzzaman, Alam Shahnur, Masaki Nakano, Seiko Ishihara, Nobuto Kakuda, Tomohiro Miyasaka, Hina Uchiyama, Yuuna Shirai, Takashi Saito, Takaomi C. Saido, et al. (2021). A potential defense mechanism against amyloid deposition in cerebellum . Biochemical and Biophysical Research Communications.

Mohammad Moniruzzaman, Seiko Ishihara, Mika Nobuhara, Hidekazu Higashide, Satoru Funamoto (2018). Glycosylation status of nicastrin influences catalytic activity and substrate preference of γ-secretase . Biochemical and Biophysical Research Communications.

PATENT

Mohammad Moniruzzaman (2024). Liquid-liquid phase separation modulating oligonucleotides.

CONFERENCE PAPER

Mohammad Moniruzzaman (2023). Oligonucleotide-based approaches for modulating FUS phase separation in ALS/FTLD intervention. SOCIETY for NEUROSCIENCE (SfN).